A new provision in the Senate FDA user fee and reform bill would prevent issuance of an FDA guidance on the regulation of mobile medical applications software until the agency submits a report to Congress.
The broad-based bill was formally introduced in the Senate May 15 and is likely to be debated on the floor this week. It was approved by the Senate Health, Education, Labor and Pensions Committee in April
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?